| Revenue | |
| General and administrative (including stock-based compensation (Note 8)) | 424.69K |
| Research and development (including stock-based compensation (Note 8)) | 112.24K |
| Total operating expenses | 537.44K |
| Loss from operations | -537.44K |
| Interest expense | 92.76K |
| Interest income | |
| Total Nonoperating Income/Expense | 92.76K |
| Net loss | -630.2K |
| Net loss attributable to the noncontrolling interest | 534 |
| Net loss attributable to Bion | |
| Conversion inducement (Note 8) | |
| Dividends on preferred stock | |
| Net loss applicable to Bion's common stockholders | -629.67K |
| Net loss applicable to Bion's common stockholders per basic and diluted common share | -0.03 |
| Basic and diluted | |